CLINICAL TRIALS PROFILE FOR FOLIGLURAX
✉ Email this page to a colleague
Clinical Trials for Foliglurax
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT03162874 ↗ | Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients | Completed | Prexton Therapeutics | Phase 2 | This will be a double-blind, randomised, placebo-controlled parallel-arm phase II proof of concept in subjects with PD treated with a stable dose of levodopa who are experiencing both end-of-dose wearing off and Levodopa-Induced Dyskinesia (LID) |
| NCT03331848 ↗ | Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED) | Withdrawn | Prexton Therapeutics | Phase 2 | This is a Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-arm Phase IIa proof of concept in subjects with PD treated with a stable dose of levodopa who are experiencing Motor Complications of Levodopa Therapy |
| NCT04002895 ↗ | What the Body Does to Foliglurax in Healthy Volunteers | Completed | H. Lundbeck A/S | Phase 1 | This study evaluates how the body takes up and gets rid of foliglurax after swallowing a liquid dose. |
| NCT04175132 ↗ | Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD) | Terminated | H. Lundbeck A/S | Phase 1 | A study to learn how foliglurax binds in regions of the brain |
| NCT04275115 ↗ | Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects | Completed | H. Lundbeck A/S | Phase 1 | The purpose of this study is to help determine which types of drugs that may interact with foliglurax |
| NCT04322227 ↗ | Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects | Terminated | H. Lundbeck A/S | Phase 1 | The purpose of this study is to investigate effects of foliglurax on brain wave patterns (electric signals) in healthy subjects and in patients with PD |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Foliglurax
Condition Name
Clinical Trial Locations for Foliglurax
Clinical Trial Progress for Foliglurax
Clinical Trial Phase
Clinical Trial Sponsors for Foliglurax
Sponsor Name
